First chikungunya vaccine approved in Europe for persons as young as 12 years old. <li /> On track for launch in key European markets i ...
Katja Michael, Ph.D., an associate professor at the University of Texas at El Paso, has been named a senior member of the ...
Katja Michael, Ph.D., an associate professor at the University of Texas at El Paso, has been named a senior member of the ...
First chikungunya vaccine approved in Europe for persons as young as 12 years old.On track for launch in key European markets in the first half of 2025. COPENHAGEN, Denmark, February 28, 2025 ...
VIMKUNYA is an adjuvanted VLP recombinant protein vaccine for active immunization for the prevention of disease caused by chikungunya virus ... 4 Ribas Freitas AR, Pinheiro Chagas AA, Siqueira AM, ...
The initiative will focus on vaccines and medicines for diseases ... says it has earmarked $100 million for new treatments for Chagas disease, leishmaniasis, dengue fever and cryptosporidiosis ...
The measles outbreak is surging in West Texas, especially in under-vaccinated communities, but it’s not just coverage with ...
A study published last month in Nature underscores the potential for a new personalized pancreatic cancer vaccine to keep the ...
Vaccination provides long-lasting 97% protection against measles infection. Most people who have been vaccinated do not need ...
A recent outbreak of measles is prompting questions about the life-threatening disease and how to prevent it. Here's what to ...
As a measles outbreak in Texas has grown to nearly 150 cases, US Health and Human Services Sec. Robert F. Kennedy Jr. said in ...